Targeted protein degradation in hematologic malignancies: clinical progression towards novel therapeutics
Crossref DOI link: https://doi.org/10.1186/s40364-024-00638-1
Published Online: 2024-08-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Feng, Yupiao
Hu, Xinting
Wang, Xin
Text and Data Mining valid from 2024-08-21
Version of Record valid from 2024-08-21
Article History
Received: 30 June 2024
Accepted: 12 August 2024
First Online: 21 August 2024
Declarations
:
: Not applicable.
: The authors declare no competing interests.